# Bioavailability of Tebipenem (SPR994) Crushed Tablet

> **NCT05296382** · PHASE1 · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 12 (actual)

## Conditions studied

- Relative Bioavailability

## Interventions

- **DRUG:** Tebipenem tablet form
- **OTHER:** Tube feeds

## Key facts

- **NCT ID:** NCT05296382
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296382, "Bioavailability of Tebipenem (SPR994) Crushed Tablet". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05296382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*